Abstract
Purpose
Oral squamous cell carcinoma (OSCC)-related deaths mainly result from invasion of the tumor cells into local cervical lymph nodes. It has been reported that progressive basement membrane loss promotes the metastatic and invasive capacities of OSCCs. Matrix metalloproteinase-9 (MMP-9) is known to play a central role in tumor progression and invasion. However, the role of MMP-9 in OSCC invasion has so far remained paradoxical and little is known about its regulation. Here, we aimed to assess MMP-9 expression regulation and its activation by glycogen synthase kinase-3β during human OSCC progression and invasion.
Methods
In the present study, 178 human OSCC samples, including 118 fresh samples (18 adjacent normal, 42 noninvasive and 58 invasive tumor samples) and 60 archival human tissue microarray (TMA) tongue cancer samples, were included. mRNA expression, protein expression, MMP-9/-2 activity, protein-protein interaction and Snail, c-Myc, β-catenin and TIMP1 expression were assessed using RT-PCR, immunohistochemistry, Western blotting, co-immunoprecipitation and gelatin zymography analyses, respectively. Wnt5a and LPA mediated MMP-9 regulation was assessed in OCSCC-derived SCC-9 cells exogenously expressing GSK3β (WT) or non phosphoryable GSK3β (S9A).
Results
We observed a progressive up-regulation/activation of MMP-9 at various stages of oral tumor progression/invasion. Positive correlations were observed between MMP-9 and c-Myc expression, MMP-9 and MMP-2 activity, MMP-9 and TIMP1 expression and MMP-9 activity and TIMP1-MMP-9 interaction. In contrast, a negative correlation between phosphorylated β-catenin and MMP-9 expression was observed. Conversely, we found that in oral tongue SCC MMP-9 expression was positively correlated with inactivation of GSK3 signaling. Finally, we found that Wnt5a and LPA mediated increased MMP-9 and decreased GSK3β activities in tongue SCC-derived SCC-9 cells. MMP-9 regulation by GSK3β was confirmed by using phosphoryable/regulatory GSK3β (WT construct) and not by non-phosphoryable GSK3β (S9A construct).
Conclusions
Collectively, our results show that MMP-9 overexpression and activation are important events occurring during OSCC progression/invasion and that this overexpression/activation is regulated by c-Myc, active MMP-2 and inactive GSK3β mediated pathways.
Similar content being viewed by others
References
J. Noguti, C.F. De Moura, G.P. De Jesus, V.H. Da Silva, T.A. Hossaka, C.T. Oshima, D.A. Ribeiro, Metastasis from oral cancer: An overview. Cancer Genomics Proteomics 9, 329–335 (2012)
L. Jimenez, S.K. Jayakar, T.J. Ow, J.E. Segall, Mechanisms of invasion in head and neck cancer. Arch Pathol Lab Med 139, 1334–1348 (2015)
M.B. Duz, O.F. Karatas, E. Guzel, N.F. Turgut, M. Yilmaz, C.J. Creighton, M. Ozen, Identification of mir-139-5p as a saliva biomarker for tongue squamous cell carcinoma: A pilot study. Cell Oncol 39, 187–193 (2016)
B. Jang, J.-A. Shin, Y.-S. Kim, J.-Y. Kim, H.-K. Yi, I.-S. Park, N.-P. Cho, S.-D. Cho, Growth-suppressive effect of suberoylanilide hydroxamic acid (saha) on human oral cancer cells. Cell Oncol 39, 79–87 (2016)
M.A. St John, G. Wang, J. Luo, M. Dohadwala, D. Hu, Y. Lin, M. Dennis, J.M. Lee, D. Elashoff, T. Lawhon, S.L. Zaknoen, F.J. Burrows, S.M. Dubinett, Apricoxib upregulates 15-pgdh and pgt in tobacco-related epithelial malignancies. Br J Cancer 107, 707–712 (2012)
D. Hanahan, R.A. Weinberg, Hallmarks of cancer: The next generation. Cell 144, 646–674 (2011)
C.R. Leemans, B.J. Braakhuis, R.H. Brakenhoff, The molecular biology of head and neck cancer. Nat Rev Cancer 11, 9–22 (2010)
K. Kessenbrock, V. Plaks, Z. Werb, Matrix metalloproteinases: Regulators of the tumor microenvironment. Cell 141, 52–67 (2010)
J.E. Rundhaug, Matrix metalloproteinases, Angiogenesis, and cancer: Commentary re: A C Lockhart et al, reduction of wound angiogenesis in patients treated with bms-275291, a broad spectrum matrix metalloproteinase inhibitor Clin Cancer res, 9: 00–00, 2003 Clin Cancer Res 9, 551–554 (2003)
B.P. Patel, S.V. Shah, S.N. Shukla, P.M. Shah, P.S. Patel, Clinical significance of mmp-2 and mmp-9 in patients with oral cancer. Head Neck 29, 564–572 (2007)
J.C. de Vicente, M.F. Fresno, L. Villalain, J.A. Vega, G. Hernandez Vallejo, Expression and clinical significance of matrix metalloproteinase-2 and matrix metalloproteinase-9 in oral squamous cell carcinoma. Oral Oncol 41, 283–293 (2005)
M. Aparna, L. Rao, V. Kunhikatta, R. Radhakrishnan, The role of mmp-2 and mmp-9 as prognostic markers in the early stages of tongue squamous cell carcinoma. J Oral Pathol Med 44, 345–352 (2015)
L.K. Makinen, V. Hayry, T. Atula, C. Haglund, H. Keski-Santti, I. Leivo, A. Makitie, F. Passador-Santos, C. Bockelman, T. Salo, T. Sorsa, J. Hagstrom, Prognostic significance of matrix metalloproteinase-2, −8, −9, and −13 in oral tongue cancer. J Oral Pathol Med 41, 394–399 (2011)
S.S. Barros, A.C. Henriques, K.M. Pereira, A.M. de Medeiros, H.C. Galvao, A. Freitas Rde, Immunohistochemical expression of matrix metalloproteinases in squamous cell carcinoma of the tongue and lower lip. Arch Oral Biol 56, 752–760 (2011)
L.M. Coussens, B. Fingleton, L.M. Matrisian, Matrix metalloproteinase inhibitors and cancer: Trials and tribulations. Science 295, 2387–2392 (2002)
D. Guttman, Y. Stern, T. Shpitzer, D. Ulanovski, T. Druzd, R. Feinmesser, Expression of mmp-9, timp-1, cd-34 and factor-8 as prognostic markers for squamous cell carcinoma of the tongue. Oral Oncol 40, 798–803 (2004)
B. Qiao, N.W. Johnson, J. Gao, Epithelial-mesenchymal transition in oral squamous cell carcinoma triggered by transforming growth factor-beta1 is snail family-dependent and correlates with matrix metalloproteinase-2 and -9 expressions. Int J Oncol 37, 663–668 (2010)
R. Mishra, Glycogen synthase kinase 3 beta: Can it be a target for oral cancer. Mol Cancer 9, 144 (2010)
R. Mishra, S. Nagini, A. Rana, Expression and inactivation of glycogen synthase kinase 3 alpha/ beta and their association with the expression of cyclin d1 and p53 in oral squamous cell carcinoma progression. Mol Cancer 14, 20 (2015)
G.R. Yedida, S. Nagini, R. Mishra, The importance of oncogenic transcription factors for oral cancer pathogenesis and treatment. Oral Surg Oral Med Oral Pathol Oral Radiol 116, 179–188 (2013)
E. Batlle, E. Sancho, C. Franci, D. Dominguez, M. Monfar, J. Baulida, A. Garcia De Herreros, The transcription factor snail is a repressor of e-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2, 84–89 (2000)
B.P. Zhou, J. Deng, W. Xia, J. Xu, Y.M. Li, M. Gunduz, M.C. Hung, Dual regulation of snail by gsk-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat Cell Biol 6, 931–940 (2004)
Z. Prgomet, L. Axelsson, P. Lindberg, T. Andersson, Migration and invasion of oral squamous carcinoma cells is promoted by wnt5a, a regulator of cancer progression. J Oral Pathol Med 44, 776–784 (2015)
N. Bhattacharya, A. Roy, B. Roy, S. Roychoudhury, C.K. Panda, Myc gene amplification reveals clinical association with head and neck squamous cell carcinoma in indian patients. J Oral Pathol Med 38, 759–763 (2009)
R. Mishra, B.R. Das, Early overexpression of cdk4 and possible role of krf and c-myc in chewing tobacco mediated oral cancer development. Mol Biol Rep 30, 207–213 (2003)
R. Fridman, M. Toth, D. Pena, S. Mobashery, Activation of progelatinase b (mmp-9) by gelatinase a (mmp-2). Cancer Res 55, 2548–2555 (1995)
I.J. Brusevold, I.H. Tveteraas, M. Aasrum, J. Ødegård, D.L. Sandnes, T. Christoffersen, 516: Role of lpar3, pkc and egfr in lpa-induced cell migration in oral squamous carcinoma cells. Eur J Cancer S124 (2014)
J.A. Lorenzo, C.C. Pilbeam, J.F. Kalinowski, M.S. Hibbs, Production of both 92- and 72-kda gelatinases by bone cells. Matrix 12, 282–290 (1992)
K.K. Pramanik, A.K. Singh, M. Alam, T. Kashyap, P. Mishra, A.K. Panda, R.K. Dey, A. Rana, S. Nagini, R. Mishra, Reversion-inducing cysteine-rich protein with kazal motifs and its regulation by glycogen synthase kinase 3 signaling in oral cancer. Tumor Biol 37, 15253–15264 (2016)
S. Mukhopadhyay, H.G. Munshi, S. Kambhampati, A. Sassano, L.C. Platanias, M.S. Stack, Calcium-induced matrix metalloproteinase 9 gene expression is differentially regulated by erk1/2 and p38 mapk in oral keratinocytes and oral squamous cell carcinoma. J Biol Chem 279, 33139–33146 (2004)
S.T. Vilen, T. Salo, T. Sorsa, P. Nyberg, Fluctuating roles of matrix metalloproteinase-9 in oral squamous cell carcinoma. ScientificWorldJournal 2013, 920595 (2013)
K.U. Ogbureke, P.M. Weinberger, S.W. Looney, L. Li, L.W. Fisher, Expressions of matrix metalloproteinase-9 (mmp-9), dentin sialophosphoprotein (dspp), and osteopontin (opn) at histologically negative surgical margins may predict recurrence of oral squamous cell carcinoma. Oncotarget 3, 286–298 (2012)
E.S. Nakamura, K. Koizumi, M. Kobayashi, I. Saiki, Inhibition of lymphangiogenesis-related properties of murine lymphatic endothelial cells and lymph node metastasis of lung cancer by the matrix metalloproteinase inhibitor mmi270. Cancer Sci 95, 25–31 (2004)
R. Paduch, The role of lymphangiogenesis and angiogenesis in tumor metastasis. Cell Oncol 39, 397–410 (2016)
K.W. Min, S.H. Lee, S.J. Baek, Moonlighting proteins in cancer. Cancer Lett 370, 108–116 (2016)
L. Li, H. Li, Role of microrna-mediated mmp regulation in the treatment and diagnosis of malignant tumors. Cancer biology & therapy 14, 796–805 (2013)
K. Si-Tayeb, A. Monvoisin, C. Mazzocco, S. Lepreux, M. Decossas, G.l. Cubel, D.l. Taras, J.-F. Blanc, D.R. Robinson, J. Rosenbaum, Matrix metalloproteinase 3 is present in the cell nucleus and is involved in apoptosis. Am J Pathol 169, 1390–1401 (2006)
J.A. Kwan, C.J. Schulze, W. Wang, H. Leon, M. Sariahmetoglu, M. Sung, J. Sawicka, D.E. Sims, G. Sawicki, R. Schulz, Matrix metalloproteinase-2 (mmp-2) is present in the nucleus of cardiac myocytes and is capable of cleaving poly (adp-ribose) polymerase (parp) in vitro. FASEB J 18, 690–692 (2004)
D.J. Marchant, C.L. Bellac, T.J. Moraes, S.J. Wadsworth, A. Dufour, G.S. Butler, L.M. Bilawchuk, R.G. Hendry, A.G. Robertson, C.T. Cheung, A new transcriptional role for matrix metalloproteinase-12 in antiviral immunity. Nat Med 20, 493–502 (2014)
M.A. Moles, J.A. Montoya, M.D. Salvago, I.R. Avila, J.J. Campillo, M. Bravo, Implications of differential expression of beta-catenin in oral carcinoma. Anticancer Res 36, 1599–1604 (2016)
T. Hu, Y.R. Lu, Bcyrn1, a c-myc-activated long non-coding rna, regulates cell metastasis of non-small-cell lung cancer. Cancer Cell Int 15, 36 (2015)
Y. Song, Q.X. Yang, F. Zhang, F. Meng, H. Li, Y. Dong, A. Han, Suppression of nasopharyngeal carcinoma cell by targeting beta-catenin signaling pathway. Cancer Epidemiol 36, e116–e121 (2012)
J. Lian, J. Tang, H. Shi, H. Li, T. Zhen, W. Xie, F. Zhang, Y. Yang, A. Han, Positive feedback loop of hepatoma-derived growth factor and beta-catenin promotes carcinogenesis of colorectal cancer. Oncotarget 6, 29357–29374 (2015)
T. Zhen, S. Dai, H. Li, Y. Yang, L. Kang, H. Shi, F. Zhang, D. Yang, S. Cai, Y. He, Y. Liang, A. Han, Macc1 promotes carcinogenesis of colorectal cancer via beta-catenin signaling pathway. Oncotarget 5, 3756–3769 (2014)
L. Sun, M.E. Diamond, A.J. Ottaviano, M.J. Joseph, V. Ananthanarayan, H.G. Munshi, Transforming growth factor-beta 1 promotes matrix metalloproteinase-9-mediated oral cancer invasion through snail expression. Mol Cancer Res 6, 10–20 (2008)
M.D. Sternlicht, Z. Werb, How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17, 463–516 (2001)
M. Perez-Sayans Garcia, J.M. Suarez-Penaranda, P. Gayoso-Diz, F. Barros-Angueira, J.M. Gandara-Rey, A. Garcia-Garcia, Tissue inhibitor of metalloproteinases in oral squamous cell carcinomas - a therapeutic target? Cancer Lett 323, 11–19 (2012)
C. Ondruschka, P. Buhtz, C. Motsch, B. Freigang, R. Schneider-Stock, A. Roessner, C. Boltze, Prognostic value of mmp-2, −9 and timp-1,-2 immunoreactive protein at the invasive front in advanced head and neck squamous cell carcinomas. Pathol Res Pract 198, 509–515 (2002)
T. Yoshizaki, Y. Maruyama, H. Sato, M. Furukawa, Expression of tissue inhibitor of matrix metalloproteinase-2 correlates with activation of matrix metalloproteinase-2 and predicts poor prognosis in tongue squamous cell carcinoma. Int J Cancer 95, 44–50 (2001)
R. Lander, T. Nasr, S.D. Ochoa, K. Nordin, M.S. Prasad, C. Labonne, Interactions between twist and other core epithelial-mesenchymal transition factors are controlled by gsk3-mediated phosphorylation. Nat Commun 4, 1542 (2013)
L. Zheng, N. Li, F. Guo, X.C. Jian, C.H. Jiang, P. Yin, A.J. Min, L. Huang, Twist-related protein 1 enhances oral tongue squamous cell carcinoma cell invasion through beta-catenin signaling. Mol Med Rep 11, 2255–2261 (2015)
C. Takahashi, Z. Sheng, T.P. Horan, H. Kitayama, M. Maki, K. Hitomi, Y. Kitaura, S. Takai, R.M. Sasahara, A. Horimoto, Y. Ikawa, B.J. Ratzkin, T. Arakawa, M. Noda, Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein reck. Proc Natl Acad Sci U S A 95, 13221–13226 (1998)
S.L. Dallas, J.L. Rosser, G.R. Mundy, L.F. Bonewald, Proteolysis of latent transforming growth factor-beta (tgf-beta )-binding protein-1 by osteoclasts. A cellular mechanism for release of tgf-beta from bone matrix. J Biol Chem 277, 21352–21360 (2002)
K.D. Cowden Dahl, J. Symowicz, Y. Ning, E. Gutierrez, D.A. Fishman, B.P. Adley, M.S. Stack, L.G. Hudson, Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent e-cadherin loss in ovarian carcinoma cells. Cancer Res 68, 4606–4613 (2008)
Acknowledgements
The authors wish to acknowledge Prof. M.K. Rai (Pathologist), Director, RIMS, Ranchi and Prof. N.K. Jha, Head Dept. of Surgery (and his colleagues) RIMS, Ranchi and the Director of CARA, Cancer Hospital, Ranchi and his colleagues Dr. M. Akhouri, Dr. Aftab A. Ansari and Dr. K. Saurav and Dr. Raghav Sharan (Clinic), Ranchi for their cooperation. The fellowship of KKP (CSIR), PM (CUJ), AKS (DBT-RA) and the financial support of DBT, New Delhi (ProjectNo.BT/PR4624/MED/30/701/2012; Departmental DBT Builder Programme No. BT/PR9028/INF/22/193/ 2013) are acknowledged.
Funding
No role except financial assistance.
Author information
Authors and Affiliations
Contributions
KKP performed the IHC, WB, RT-PCR and zymography experiments; KKP, PM, AKS, MA, TK and NN performed the cell culture experiments; KKP and RM analyzed the results. RM, SN and AR provided their knowledge of biochemistry and molecular biology. RM has written the MS and the final version of the MS has been approved by all the authors.
Corresponding author
Ethics declarations
Conflicts of interest
None declared.
Electronic supplementary material
13402_2017_358_MOESM1_ESM.jpg
The quantitative expression of associated molecules that comes under GSK3β pathway and may promotes the activation of MMP-9 in SCC-9 cells. Quantitative expression (mean and SD) of representative immunoblots (WB) of (A1) β-catenin, (A2) c-myc (A3) Twist, (A4) MMP9 protein expression; and gel picture (RT-PCR) of (A5) MMP-9, (A6) MMP-2 and (A7) TIMP-2, showing the differential expression, at various treated conditions, as indicated in the figure. (* p < 0.05, **p < 0.01, ***p < 0.001). (JPEG 200 kb)
Rights and permissions
About this article
Cite this article
Pramanik, K.K., Nagini, S., Singh, A.K. et al. Glycogen synthase kinase-3β mediated regulation of matrix metalloproteinase-9 and its involvement in oral squamous cell carcinoma progression and invasion. Cell Oncol. 41, 47–60 (2018). https://doi.org/10.1007/s13402-017-0358-0
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13402-017-0358-0